UNI-DEB

DEVICE2 trials

Sponsors

Jeil Pharmaceutical Co., Ltd.

Conditions

Hepatocellular Carcinoma Non-resectable

Unknown Phase

Clinical Trial to Evaluate the Efficacy and Safety of UNI-DEB for Unresectable Hepatocellular Carcinoma

CompletedNCT03533920

Jeil Pharmaceutical Co., Ltd.Hepatocellular Carcinoma Non-resectable

Start: 2017-10-25End: 2018-09-03Updated: 2018-10-01

Pilot Clinical Trial to Evaluate the UNI-DEB for Unresectable Hepatocellular Carcinoma

CompletedNCT03564405

Jeil Pharmaceutical Co., Ltd.Hepatocellular Carcinoma Non-resectable

Start: 2016-12-05End: 2017-05-17Updated: 2018-06-21